NewsPress Release Cortexyme Announces Pipeline Update and Anticipated 2021 Milestones By admin | News, Press Release
EventsPress Release Cortexyme’s Phase 2/3 GAIN Trial of Atuzaginstat (COR388) in Patients with Alzheimer’s Disease Successfully Advances Past Interim Analysis By admin | Events, Press Release
Press Release Cortexyme Announces GAIN Trial of Atuzaginstat in Alzheimer’s Disease Has Exceeded Study Enrollment Target of 570 Patients By admin | Press Release
EventsPress Release Cortexyme Announces Oral Presentation on COR388 at Clinical Trials on Alzheimer’s Disease 2019 By admin | Events, Press Release
NewsPress Release Cortexyme Announces Phase 2/3 Clinical Trial Based on Transformational Understanding of Alzheimer’s Disease By admin | News, Press Release
